Russell Investments Group, Ltd. - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 140 filers reported holding SERES THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$15,922
+12.4%
21,998
+20.2%
0.00%
Q1 2024$14,166
-44.7%
18,3000.0%0.00%
Q4 2023$25,620
-41.2%
18,3000.0%0.00%
Q3 2023$43,554
-50.3%
18,3000.0%0.00%
Q2 2023$87,657
-15.5%
18,3000.0%0.00%
Q1 2023$103,761
+1.2%
18,3000.0%0.00%
Q4 2022$102,480
-12.4%
18,3000.0%0.00%
Q3 2022$117,000
-47.3%
18,300
-72.0%
0.00%
Q2 2022$222,000
-56.0%
65,297
-8.0%
0.00%
-100.0%
Q1 2022$504,000
-35.5%
70,975
-24.6%
0.00%0.0%
Q4 2021$782,000
+515.7%
94,125
+414.3%
0.00%
Q3 2021$127,000
-70.9%
18,3000.0%0.00%
-100.0%
Q2 2021$436,000
+16.0%
18,3000.0%0.00%0.0%
Q1 2021$376,000
+61.4%
18,300
+92.3%
0.00%
Q4 2020$233,000
-33.8%
9,517
-87.1%
0.00%
-100.0%
Q2 2020$352,000
+56.4%
74,035
+16.9%
0.00%0.0%
Q1 2020$225,000
+11.4%
63,334
+7.4%
0.00%
Q4 2019$202,000
+19.5%
58,963
+139.7%
0.00%
Q1 2019$169,000
+67.3%
24,600
+10.8%
0.00%
Q4 2018$101,000
+18.8%
22,200
+91.4%
0.00%
Q1 2018$85,000
-16.7%
11,600
+17.2%
0.00%
Q4 2017$102,000
+175.7%
9,900
+166.8%
0.00%
Q4 2016$37,0003,7110.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$148,411,0006.25%
Eversept Partners, LP 1,935,825$12,427,9971.08%
Kynam Capital Management, LP 772,820$4,962,0001.05%
SILVERARC CAPITAL MANAGEMENT, LLC 366,493$2,353,0000.80%
Lion Point Capital, LP 626,803$3,228,0000.71%
FEDERATED HERMES, INC. 18,499,136$118,765,0000.35%
Knott David M Jr 110,000$706,0000.30%
Atom Investors LP 108,820$699,0000.25%
Ikarian Capital, LLC 131,310$843,0000.17%
HARVARD MANAGEMENT CO INC 131,847$846,0000.10%
View complete list of SERES THERAPEUTICS INC shareholders